1887

Abstract

The ‘protein-only’ hypothesis of prion propagation argues that infectious prions consist of PrP(Sc), a conformational isomer of host-derived prion protein (PrP(C)), which can be distinguished from PrP(C) by its partial resistance to proteases. While protease-resistant PrP has been produced by mixing PrP(Sc) and recombinant-derived PrP(C) in vitro, bioassay of any new infectivity has been precluded by the need to use a large molar excess of same species PrP(Sc). Transgenic mice expressing a chimaeric hamster-mouse PrPC (MH2M PrP(C)) are, unlike conventional mice, highly susceptible to Sc237 hamster scrapie. In addition, they produce MH2M PrP(Sc) and infectivity which is pathogenic for conventional mice. We have therefore attempted to produce MH2M PrP(Sc) in vitro as any infectivity produced could be distinguished from the hamster PrP(Sc) used to promote the conversion by bioassay in conventional mice. Although protease-resistant MH2M PrP was produced, no infectivity was detected on bioassay. These results argue that acquisition of protease resistance by PrP(C) is not sufficient for the propagation of infectivity.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-1-11
1999-01-01
2022-05-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/1/0800011a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-1-11&mimeType=html&fmt=ahah

References

  1. Antoniou M. 1991; Induction of erythroid-specific expression in murine erythroleukaemia (MEL) cell lines. In Methods in Molecular Biology vol 7 Gene Transfer and Expression Protocols 1st edn, pp 421–433 Edited by Murray E. J. Clifton. NJ: Humana Press;
    [Google Scholar]
  2. Bessen R. A., Kocisko D. A., Raymond G. J., Nandan S., Lansbury P. T., Caughey B. 1995; Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375:698–700
    [Google Scholar]
  3. Bueler H., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M., Weissmann C. 1993; Mice devoid of PrP are resistant to scrapie. Cell 73:1339–1347
    [Google Scholar]
  4. Caughey B., Raymond G. J., Kocisko D. A., Lansbury P. T. Jr 1997; Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. Journal of Virology 71:4107–4110
    [Google Scholar]
  5. Collinge J., Palmer M. S., Sidle K. C. L., Gowland I., Medori R., Ironside J., Lantos P. L. 1995; Transmission of fatal familial insomnia to laboratory animals. Lancet 346:569–570
    [Google Scholar]
  6. Collinge J., Sidle K. C. L., Meads J., Ironside J., Hill A. F. 1996; Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685–690
    [Google Scholar]
  7. Hsiao K. K., Groth D., Scott M., Yang S.-L., Serban H., Rapp D., Foster D., Torchia M., DeArmond S. J., Prusiner S. B. 1994; Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proceedings of the National Academy of Sciences, USA 91:9126–9130
    [Google Scholar]
  8. Hsiao K. K., Scott M., Foster D., Groth D. F., DeArmond S. J., Prusiner S. B. 1990; Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587–1590
    [Google Scholar]
  9. Kascsak R. J., Rubenstein R., Merz P. A., Tonna DeMasi M., Fersko R., Carp R. I., Wisniewski H. M., Diringer H. 1987; Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. Journal of Virology 61:3688–3693
    [Google Scholar]
  10. Kocisko D. A., Come J. H., Priola S. A., Chesebro B., Raymond G. J., Lansbury P. T., Caughey B. 1994; Cell-free formation of protease-resistant prion protein. Nature 370:471–474
    [Google Scholar]
  11. Kocisko D. A., Priola S. A., Raymond G. J., Chesebro B., Lansbury P. T. Jr, Caughey B. 1995; Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proceedings of the National Academy of Sciences, USA 92:3923–3927
    [Google Scholar]
  12. Lasmezas C. I., Deslys J.-P., Robain O., Jaegly A., Beringue V., Peyrin J.-M., Fournier J.-G., Hauw J.-J., Rossier J., Dormont D. 1997; Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402–405
    [Google Scholar]
  13. Needham M., Egerton M., Millest A., Evans S., Popplewell M., Cerillo G., McPheat J., Monk A., Jack A., Johnstone D. and others 1995; Further development of the locus control region/murine erythroleukemia expression system: high level expression and characterization of recombinant human calcitonin receptor. Protein Expression and Purification 6:124–131
    [Google Scholar]
  14. Pan K.-M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R. J., Cohen F. E., Prusiner S. B. 1993; Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences, USA 90:10962–10966
    [Google Scholar]
  15. Prusiner S. B. 1987; Bioassays of prions. In Prions: Novel Infectious Pathogens causing Scrapie and Creutzfeldt–Jakob Disease pp 65–81 Edited by Prusiner S. B., McKinley M. P. San Diego: Academic Press;
    [Google Scholar]
  16. Prusiner S. B. 1991; Molecular biology of prion diseases. Science 252:1515–1522
    [Google Scholar]
  17. Prusiner S. B., Bolton D. C., Groth D. F., Bowman K., Cochran S. P., McKinley M. P. 1982; Further purification and characterization of scrapie prions. Biochemistry 21:6942–6950
    [Google Scholar]
  18. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Walchli M., Torchia M., Groth D., Carlson G., DeArmond S. J., Westaway D., Prusiner S. B. 1989; Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59:847–857
    [Google Scholar]
  19. Scott M. R., Kohler R., Foster D., Prusiner S. B. 1992; Chimeric prion protein expression in cultured cells and transgenic mice. Protein Science 1:986–997
    [Google Scholar]
  20. Scott M., Groth D., Foster D., Torchia M., Yang S. L., DeArmond S. J., Prusiner S. B. 1993; Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73:979–988
    [Google Scholar]
  21. Telling G. C., Parchi P., DeArmond S. J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., Prusiner S. B. 1996; Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079–2082
    [Google Scholar]
  22. Weissmann C. 1991; Spongiform encephalopathies. The prion′s progress. Nature 349:569–571
    [Google Scholar]
  23. Xi Y. G., Ingrosso L., Ladogana A., Masullo C., Pocchiari M. 1992; Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 356:598–601
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-1-11
Loading
/content/journal/jgv/10.1099/0022-1317-80-1-11
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error